Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

This article is part of the supplement: Beyond the Genome 2011

Open Access Invited speaker presentation

Are clinical genomes already becoming semi-routine for patient care?

Mark Boguski

  • Correspondence: Mark Boguski

Author Affiliations

Harvard Medical School, Boston, MA, USA

Genome Biology 2011, 12(Suppl 1):I3  doi:10.1186/gb-2011-12-s1-i3


The electronic version of this article is the complete one and can be found online at: http://genomebiology.com/2011/12/S1/I3


Published:19 September 2011

© 2011 Boguski; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Invited speaker presentation

Hardly a month goes by without a new published report of a patient’s genome being used diagnostically for clinical management in a diverse spectrum of disease areas, including gastroenterology, nephrology, neurology and oncology. The impression is that clinical genomics is already becoming semi-routine. However, a large and complex set of non-technical barriers needs to be overcome before genomics can truly be integrated into the practice of medicine and made widely available for patient care. Through the use of case studies, my presentation will elucidate issues relating to the needs and requirements of the workforce, the legal and regulatory aspects of ‘laboratory-developed tests’ and insurance reimbursement for ‘multi-analyte diagnostics’. The roles of the Food and Drug Administration, the Centers for Medicare & Medicaid Services and the College of American Pathologists will be highlighted.